Literature DB >> 16170810

Twelve years of the Brazilian External Quality Assessment Program in Immunohematology: benefits of the program.

Laércio Melo1, Jordão Pellegrino, Celso Bianco, Lilian Castilho.   

Abstract

The Brazilian External Quality Assessment Program in Immunohematology (BEQAPI) was introduced with the objective of evaluating the quality of diagnosis in immunohematology. From 1992 to 2003, proficiency tests for ABO grouping, Rh (D, C, c, E, e), K phenotyping, direct antiglobulin testing (DAT), antibody screening (AS), and antibody identification (AI) were performed. A total of 41 evaluations were carried out in 223 institutions. Over the period of 12 years, the program included 8,014 ABO typing, 8,000 RhD typing, 5,193 Rh typing (C, c, E, e), 5,101 K phenotyping, 7,939 AS, 4,533 AI, and 7,912 DATs. Erroneous responses were classified as clerical, technical, or undetermined. A substantial proportion of erroneous responses due to clerical errors occurred in ABO typing (76/76 errors), RhD typing (34/58 errors), and Rh phenotyping (50/73 errors). Technical errors occurred predominantly for weak D (91/95 errors), AS (252/301 errors), and AI (321/335 errors). Based on these results, since 1996, participants have received "Questions and Case Studies" in Immunohematology as an incentive for training and education. The results of the present study show an improvement in the performance of participants in the course of the program. We found that a well-organized external proficiency program can contribute to the improvement of quality of testing in Immunohematology. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16170810      PMCID: PMC6808094          DOI: 10.1002/jcla.20080

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  10 in total

1.  Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions.

Authors:  A A Pineda; E C Vamvakas; L D Gorden; J L Winters; S B Moore
Journal:  Transfusion       Date:  1999-10       Impact factor: 3.157

2.  Human error-a significant cause of transfusion mortality.

Authors:  B A Myhre; D McRuer
Journal:  Transfusion       Date:  2000-07       Impact factor: 3.157

3.  The United Kingdom National External Quality Assessment Scheme (blood transfusion laboratory practice): trends in proficiency and practice between 1985 and 2000.

Authors:  S M Knowles; C E Milkins; J F Chapman; M Scott
Journal:  Transfus Med       Date:  2002-02       Impact factor: 2.019

4.  A report of 104 transfusion errors in New York State.

Authors:  J V Linden; B Paul; K P Dressler
Journal:  Transfusion       Date:  1992-09       Impact factor: 3.157

5.  The gel test: a new way to detect red cell antigen-antibody reactions.

Authors:  Y Lapierre; D Rigal; J Adam; D Josef; F Meyer; S Greber; C Drot
Journal:  Transfusion       Date:  1990-02       Impact factor: 3.157

Review 6.  New technologies for red-cell serology.

Authors:  R C Knight; M de Silva
Journal:  Blood Rev       Date:  1996-06       Impact factor: 8.250

7.  Reports of 355 transfusion-associated deaths: 1976 through 1985.

Authors:  K Sazama
Journal:  Transfusion       Date:  1990-09       Impact factor: 3.157

8.  Evaluation of recent techniques for detection of red blood cell antibodies in sera of reference samples, patients, pregnant women, and blood donors.

Authors:  L M de Castilho; J Pellegrino; A P Bechelli; P Y Le Pennec; N F Mendes
Journal:  J Clin Lab Anal       Date:  1996       Impact factor: 2.352

9.  What is the best technique for the detection of red cell alloantibodies?

Authors: 
Journal:  Vox Sang       Date:  1995       Impact factor: 2.144

10.  Transfusion errors in New York State: an analysis of 10 years' experience.

Authors:  J V Linden; K Wagner; A E Voytovich; J Sheehan
Journal:  Transfusion       Date:  2000-10       Impact factor: 3.157

  10 in total
  1 in total

1.  Participation in proficiency programs and promotion of quality in transfusion services of Minas Gerais.

Authors:  Angela Melgaço Ferreira; Stela Brener; Ricardo Vilas Freire de Carvalho; Marcele Cunha Ribeiro do Valle; Helio Moraes-Souza
Journal:  Rev Bras Hematol Hemoter       Date:  2012
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.